or
forgot password

International Registry for Intraductal Papillary Mucinous Neoplasma


N/A
18 Years
N/A
Open (Enrolling)
Both
Pancreatic Cysts

Thank you

Trial Information

International Registry for Intraductal Papillary Mucinous Neoplasma


Inclusion Criteria:



- Suspected IPMN based on the consensus guidelines (7)

- Endoscopic ultrasound imaging at baseline examination

- Either surgical histology or clinical follow up with EUS, MRI, or CT scan for at
least 1 year

- Cases previously collected that meet the above criteria will be allowed

Exclusion Criteria:

- Patients who do not meet the above inclusion criteria

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Outcome Measure:

Identify clinical and morphological predictors of cancer or high grade dysplasia in patients with IPMN. Identify predictors of progression to cancer or high grade dysplasia among patients who are followed in surveillance programs.

Outcome Time Frame:

End of study

Safety Issue:

No

Principal Investigator

Michele D Lewis, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Institutional Review Board

Study ID:

07-007845

NCT ID:

NCT00828048

Start Date:

March 2008

Completion Date:

January 2014

Related Keywords:

  • Pancreatic Cysts
  • Pancreatic Cyst

Name

Location
Mayo Clinic Jacksonville Jacksonville, Florida  32224